Resistance Training in Lung Cancer Patients on Chemotherapy

Not Applicable

Completed

• Conditions: Lung Cancer; Inflammation

• Registration Number: NCT01130714
• Lead Sponsor: East Carolina University

Brief Summary

The purpose of this study is to examine the effectiveness of a resistance training program on reducing systemic inflammation and improving chemotherapy completion in lung cancer patients being treated with curative intent chemotherapy.

Detailed Description

Not available

Study Timeline

• Study Start: 2010-01
• Study First Submitted: 2010-01-06
• Study First Submitted QC: 2010-05-25
• Study First Posted: 2010-05-26
• Primary Completion: 2012-07
• Study Completion: 2012-07
• Status Verified: 2015-08
• Last Update Submitted: 2015-08-19
• Last Update Posted: 2015-08-20

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 15

Inclusion Criteria

• Histologically diagnosed with lung cancer
• Stage I, II, or III
• Eligible for chemotherapy with curative intent
• 21 years of age or older
• Approval to participate in study by treating oncologist or family physician

Exclusion Criteria

• Unstable cardiac disease
• Untreated bone or brain metastases

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Primary Outcome Measures

Name	Time	Method
Systemic inflammation measured by c-reactive protein.	12 weeks

Secondary Outcome Measures

Name	Time	Method
Chemotherapy completion	12 weeks

Trial Locations

Locations (1)

Leo Jenkins Cancer Center; 🇺🇸 Greenville, North Carolina, United States